151 related articles for article (PubMed ID: 19806915)
1. [Synthesis and in vitro cytotoxicity of naphthalimide polyamine conjugates as antitumor agents].
Mei ZH; Tian ZY; Ma HX; Xie SQ; Zhao J; Wang CJ
Yao Xue Xue Bao; 2009 Jul; 44(7):754-7. PubMed ID: 19806915
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, cytotoxicity and apoptosis of naphthalimide polyamine conjugates as antitumor agents.
Tian ZY; Xie SQ; Du YW; Ma YF; Zhao J; Gao WY; Wang CJ
Eur J Med Chem; 2009 Jan; 44(1):393-9. PubMed ID: 18423800
[TBL] [Abstract][Full Text] [Related]
3. Novel naphthalimide-benzoic acid conjugates as potential apoptosis-inducing agents: design, synthesis, and biological activity.
Wu A; Mei P; Xu Y; Qian X
Chem Biol Drug Des; 2011 Dec; 78(6):941-7. PubMed ID: 21958160
[TBL] [Abstract][Full Text] [Related]
4. Unprecedented synthesis, in vitro and in vivo anti-cancer evaluation of novel triazolonaphthalimide derivatives.
Li S; Zhong W; Li Z; Meng X
Eur J Med Chem; 2012 Jan; 47(1):546-52. PubMed ID: 22138307
[TBL] [Abstract][Full Text] [Related]
5. Novel naphthalimide-amino acid conjugates with flexible leucine moiety as side chain: design, synthesis and potential antitumor activity.
Wu A; Xu Y; Qian X
Bioorg Med Chem; 2009 Jan; 17(2):592-9. PubMed ID: 19109022
[TBL] [Abstract][Full Text] [Related]
6. 5-Non-amino aromatic substituted naphthalimides as potential antitumor agents: Synthesis via Suzuki reaction, antiproliferative activity, and DNA-binding behavior.
Xie L; Cui J; Qian X; Xu Y; Liu J; Xu R
Bioorg Med Chem; 2011 Jan; 19(2):961-7. PubMed ID: 21208805
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, DNA Binding, and Anticancer Properties of Bis-Naphthalimide Derivatives with Lysine-Modified Polyamine Linkers.
Huang Y; Wu CX; Song Y; Huang M; Tian DN; Yang XB; Fan YR
Molecules; 2018 Jan; 23(2):. PubMed ID: 29382135
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of new amonafide analogues via coupling reaction and their cytotoxic evaluation and DNA-binding studies.
Xie L; Xu Y; Wang F; Liu J; Qian X; Cui J
Bioorg Med Chem; 2009 Jan; 17(2):804-10. PubMed ID: 19070496
[TBL] [Abstract][Full Text] [Related]
9. Oxo-heterocyclic fused naphthalimides as antitumor agents: synthesis and biological evaluation.
Tan S; Yin H; Chen Z; Qian X; Xu Y
Eur J Med Chem; 2013 Apr; 62():130-8. PubMed ID: 23353750
[TBL] [Abstract][Full Text] [Related]
10. The novel anti-tumor agents of 4-triazol-1,8-naphthalimides: synthesis, cytotoxicity, DNA intercalation and photocleavage.
Li X; Lin Y; Wang Q; Yuan Y; Zhang H; Qian X
Eur J Med Chem; 2011 Apr; 46(4):1274-9. PubMed ID: 21345546
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of naphthalimide-polyamine conjugates modified by alkylation as anticancer agents through p53 pathway.
Dai F; He H; Xu X; Chen S; Wang C; Feng C; Tian Z; Dong H; Xie S
Bioorg Chem; 2018 Apr; 77():16-24. PubMed ID: 29316508
[TBL] [Abstract][Full Text] [Related]
12. Conjugation of substituted naphthalimides to polyamines as cytotoxic agents targeting the Akt/mTOR signal pathway.
Tian ZY; Xie SQ; Mei ZH; Zhao J; Gao WY; Wang CJ
Org Biomol Chem; 2009 Nov; 7(22):4651-60. PubMed ID: 19865701
[TBL] [Abstract][Full Text] [Related]
13. DNA binding and anticancer activity of naphthalimides with 4-hydroxyl-alkylamine side chains at different lengths.
Wang K; Wang Y; Yan X; Chen H; Ma G; Zhang P; Li J; Li X; Zhang J
Bioorg Med Chem Lett; 2012 Jan; 22(2):937-41. PubMed ID: 22200595
[TBL] [Abstract][Full Text] [Related]
14. A naphthalimide-polyamine conjugate preferentially accumulates in hepatic carcinoma metastases as a lysosome-targeted antimetastatic agent.
Ma J; Li L; Yue K; Zhang Z; Su S; Chen Y; Yu L; Zhang P; Ma R; Li Y; Ma Y; Jia H; Wang C; Wang J; Xie S
Eur J Med Chem; 2021 Oct; 221():113469. PubMed ID: 33965862
[TBL] [Abstract][Full Text] [Related]
15. [Acetylsalicylic acid strengthens the effects of ANISpm against hepatocellular carcinoma and its molecular mechanism].
Xie SQ; Zhang LL; Yang T; Ma Y; Zhang YH; Li Q; Wang JH; Zhao J; Wang CJ
Yao Xue Xue Bao; 2011 Sep; 46(9):1045-50. PubMed ID: 22121773
[TBL] [Abstract][Full Text] [Related]
16. Molecular design, chemical synthesis, and biological evaluation of '4-1' pentacyclic aryl/heteroaryl-imidazonaphthalimides.
Li F; Cui J; Guo L; Qian X; Ren W; Wang K; Liu F
Bioorg Med Chem; 2007 Aug; 15(15):5114-21. PubMed ID: 17532640
[TBL] [Abstract][Full Text] [Related]
17. Novel N-oxide of naphthalimides as prodrug leads against hypoxic solid tumor: synthesis and biological evaluation.
Yin H; Xu Y; Qian X; Li Y; Liu J
Bioorg Med Chem Lett; 2007 Apr; 17(8):2166-70. PubMed ID: 17331719
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activities of 6-amino amonafide derivatives.
Norton JT; Witschi MA; Luong L; Kawamura A; Ghosh S; Stack MS; Sim E; Avram MJ; Appella DH; Huang S
Anticancer Drugs; 2008 Jan; 19(1):23-36. PubMed ID: 18043127
[TBL] [Abstract][Full Text] [Related]
19. Novel naphthalimide derivatives as potential apoptosis-inducing agents: design, synthesis and biological evaluation.
Wu A; Xu Y; Qian X; Wang J; Liu J
Eur J Med Chem; 2009 Nov; 44(11):4674-80. PubMed ID: 19643513
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Characterization, Quantum-Chemical Calculations and Cytotoxic Activity of 1,8-Naphthalimide Derivatives with Non-Protein Amino Acids.
Marinov MN; Naydenova ED; Momekov GT; Prodanova RY; Markova NV; Voynikov YT; Stoyanov NM
Anticancer Agents Med Chem; 2019; 19(10):1276-1284. PubMed ID: 30848212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
